Joshua Schafer - Net Worth and Insider Trading
Joshua Schafer Net Worth
The estimated net worth of Joshua Schafer is at least $16,275 dollars as of 2024-06-08. Joshua Schafer is the CCO & EVP, Bus. Development of Zevra Therapeutics Inc and owns about 3,500 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $16,275. Details can be seen in Joshua Schafer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joshua Schafer has not made any transactions after 2023-09-05 and currently still holds the listed stock(s).
Transaction Summary of Joshua Schafer
Joshua Schafer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joshua Schafer owns 2 companies in total, including Zevra Therapeutics Inc (ZVRA) , and Shuttle Pharmaceuticals Holdings Inc (SHPH) .
Click here to see the complete history of Joshua Schafer’s form 4 insider trades.
Insider Ownership Summary of Joshua Schafer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2023-09-05 | CCO & EVP & Bus. Development |
| SHPH | Shuttle Pharmaceuticals Holdings Inc | 2022-08-29 | director |
Joshua Schafer Latest Holdings Summary
Joshua Schafer currently owns a total of 1 stock. Joshua Schafer owns 3,500 shares of Zevra Therapeutics Inc (ZVRA) as of September 5, 2023, with a value of $16,275.
Latest Holdings of Joshua Schafer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2023-09-05 | 3,500 | 4.65 | 16,275 |
Holding Weightings of Joshua Schafer
Joshua Schafer Form 4 Trading Tracker
According to the SEC Form 4 filings, Joshua Schafer has made a total of 3 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 500 shares on September 5, 2023, which cost Joshua Schafer around $2,565.
Insider Trading History of Joshua Schafer
- 1
Joshua Schafer Trading Performance
GuruFocus tracks the stock performance after each of Joshua Schafer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua Schafer is 4.64%. GuruFocus also compares Joshua Schafer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua Schafer within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joshua Schafer's insider trading performs compared to the benchmark.
Performance of Joshua Schafer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.98 | | | | | |
| Relative Return to S&P 500(%) | 8.17 | | | | | |
Joshua Schafer Ownership Network
Joshua Schafer Owned Company Details
What does Zevra Therapeutics Inc do?
Who are the key executives at Zevra Therapeutics Inc?
Joshua Schafer is the CCO & EVP & Bus. Development of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include director & President and CEO Neil F. Mcfarlane , VP Fin & Corp Controller R. Laduane Clifton , and VP & Corporate Controller Timothy J. Sangiovanni .
Zevra Therapeutics Inc (ZVRA) Insider Trades Summary
Over the past 18 months, Joshua Schafer made 3 insider transaction in Zevra Therapeutics Inc (ZVRA) with a net purchase of 3,500. Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 6,100 shares made by R. Laduane Clifton , a net purchase of 1,000 shares made by Watton Corey Michael , and a net purchase of 20,000 shares made by John B Bode .
In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 77,819 shares were bought by its insiders, resulting in a net purchase of 77,819 shares.
Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zevra Therapeutics Inc Insider Transactions
Joshua Schafer Mailing Address
Above is the net worth, insider trading, and ownership report for Joshua Schafer. You might contact Joshua Schafer via mailing address: Shuttle Pharmaceuticals Holdings, Inc., One Research Court, Suite 450, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
